HIGHLIGHTS
- who: Ronald J. Corbee from the Federal University of Rio Grande do Sul, Brazil have published the research: Fibroblast growth factor-21 (FGF21) analogs as possible treatment options for diabetes mellitus in veterinary patients, in the Journal: (JOURNAL)
- what: Because the FGF21 analogs may have potential in the treatment of pets with DM, the aim of this study was to review the recent literature regarding the use of FGF21 (analogs). Side effects such as diarrhea, bone resorption, and increased heart rate and blood pressure have been reported in the studies, which is one of the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.